FDA guidance on off-label promotion and the state of the literature from sponsors.
Psaty
Bruce M
BM
Cardiovascular Health Research Unit, Department of Medicine, University of Washington, Seattle, Washington, USA. psaty@u.washington.edu
Ray
Wayne
W
D017277:Drug Approval; D004345:Drug Industry; D004348:Drug Labeling; D017408:Guidelines as Topic; D007880:Legislation, Drug; D011643:Publishing; D014481:United States; D014486:United States Food and Drug Administration